| JAQBO® Tab. 20 mg(Zastaprazan Citrate) in Erosive GERD (NCT07115706) | Jeil Pharmaceutical Co., Ltd. | 2025-08-25 |
| Observationa Study is a Prospective and Multi-institutional Observational Study. (NCT06952855) | Jeil Pharmaceutical Co., Ltd. | 2024-11-01 |
| To Evaluate the Safety, Pharmacokinetic Characteristics and the Effect of Food After Administration of JLP-2004 (NCT06431399) | Jeil Pharmaceutical Co., Ltd. | 2024-04-23 |
| Evaluation of Efficacy and Safety When Administered JP-2266 in Type 2 Diabetes Patients (NCT06144788) | Jeil Pharmaceutical Co., Ltd. | 2023-11-03 |
| To Evaluate the Safety and Pharmacokinetic Characteristics After Multiple Administration of JC-013 and JLP-2004 (NCT06169059) | Jeil Pharmaceutical Co., Ltd. | 2023-10-05 |
| To Evaluate the Safety and Pharmacokinetic Characteristics After the Administration of JT-001, JT-002 and JLP-2008 (NCT06165965) | Jeil Pharmaceutical Co., Ltd. | 2022-05-03 |
| To Evaluate the Efficacy and Safety of JT-003 add-on in Patients With Type 2 Diabetes Mellitus Inadequately Controlled With Metformin and Dapagliflozin (NCT05296044) | Jeil Pharmaceutical Co., Ltd. | 2022-04-05 |
| To Evaluate the Safety and Pharmacokinetic Characteristics After the Administration of JC-001 and JLP-1901 (NCT06171880) | Jeil Pharmaceutical Co., Ltd. | 2022-02-15 |
| To Evaluate the Efficacy and Safety of JT-001 add-on in Paatients With Type 2 Diabetes Mellitus Inadequately Controlled With Metformin and Dapagliflozin (NCT05101135) | Jeil Pharmaceutical Co., Ltd. | 2021-11-17 |
| A Study of Lubiprostone to Treat Constipation (NCT04861233) | Jeil Pharmaceutical Co., Ltd. | 2021-09-01 |
| The Safety and PK Characteristics of the Co-administration of JLP-2002 and Comparator in Healthy Volunteers (NCT04914221) | Jeil Pharmaceutical Co., Ltd. | 2021-03-13 |
| Safety, Tolerability, and Pharmacokinetic and Pharmacodynamic Characteristics of JP-2266 in Healthy Subjects (NCT05172622) | Jeil Pharmaceutical Co., Ltd. | 2020-11-24 |
| To Evaluate the Efficacy and Safety of JLP-2002 on Symptoms of Overactive Bladder (NCT04917315) | Jeil Pharmaceutical Co., Ltd. | 2020-05-21 |
| The PK Characteristics of the Co-administration of Rosuvastatin and Telmisartan/Amlodipine and JLP-1401 in Healthy Adult Volunteers Volunteers (NCT03707899) | Jeil Pharmaceutical Co., Ltd. | 2018-12-13 |
| The PK Characteristics of the Co-administration of Metformin SR and Rosuvastatin and JLP-1310 in Healthy Male Volunteers. (NCT03690778) | Jeil Pharmaceutical Co., Ltd. | 2018-10-04 |
| Clinical Trial to Investigate the Safety, Tolerability and Pharmacokinetics and Pharmacodynamics of JP-1366 Oral Administration in Healthy Male Subjects (NCT03383042) | Jeil Pharmaceutical Co., Ltd. | 2017-12-22 |
| Clinical Trial to Evaluate the Efficacy and Safety of UNI-DEB for Unresectable Hepatocellular Carcinoma (NCT03533920) | Jeil Pharmaceutical Co., Ltd. | 2017-10-25 |